Safety of heparin reversal with protamin and immediate sheath removal after coronary angioplasty

Acta Radiologica

Volumn 45, Issue 2, 2004, Pages 171-175

  Lohne, F ^a   Kløw, Nils Einar ^a   Stavnes, S ^a   Brekke, M ^a   Hoffmann, P ^a   Stensaeth K H ^a   Sovik E ^a   Pettersen, M S ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adverse events; Angioplasty; Heparin; Immobilization; Protamin; Puncture site

Indexed keywords

ANGIOGRAPHY; INFORMATION ANALYSIS; PATIENT MONITORING; PATIENT TREATMENT; SURGERY; ULTRASONICS;

ADVERSE EVENTS; ANGIOPLASTY; HEPARIN; IMMOBILIZATION; PROTAMIN; PUNCTURE SITE;

RADIOLOGY;

ANTICOAGULANT AGENT; HEPARIN; ISOPHANE INSULIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE REMOVAL; FEMALE; FEMORAL ARTERY; HEMOSTASIS; HUMAN; INSTRUMENTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PUNCTURE; RANDOMIZED CONTROLLED TRIAL; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; DEVICE REMOVAL; FEMALE; FEMORAL ARTERY; HEMOSTATIC TECHNIQUES; HEPARIN; HUMANS; INSULIN, ISOPHANE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PUNCTURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 2442553966     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841850410003743     Document Type: Article

References (19)

1. Berlis A, Schumacher M. Anticoagulation control during neuroradiological interventions with ACT (activated clotting time). Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1999;170:378-83.
2. Blanco C, Castillo R, Quiralte J, Delgado J, Garcia I, de Pablos P, et al. Anaphylaxis to subcutaneous neutral protamin hagedorn insulin with simultaneous sensitization to protamin and insulin. Allergy 1996;51:421-4.
3. Briguori C, Di Mario C, De Gregorio J, Sheiban I, Vaghetti M, Colombo A. Administration of protamine after coronary stent deployment. Am Heart J 1999;138:64-8.
4. Chew DP, Bhatt DL, Lincoff AM, Moliterno DJ, Brener SJ, Wolski KE, et al. Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials. Circulation 2001;103:961-6.
5. Ducas J, Chan MC, Miller A, Kashour T. Immediate protamine administration and sheath removal following percutaneous coronary intervention: a prospective study of 429 patients. Catheter Cardiovasc Interv 2002;56:196-9.
6. Garachemani AR, Kaufmann U, Fleisch M, Meier B. Prolonged heparin after uncomplicated coronary interventions: a prospective, randomized trial. Am Heart J 1998;136:352-6.
7. Hakala T, Suojaranta-Ylinen R. Fatal anaphylactic reaction to protamine after femoropopliteal by-pass surgery. Ann Chir Gynaecol 1996;89:150-2.
8. Kaluski E, Krakover R, Cotter G, Hendler A, Zyssman I, Milovanov O, et al. Minimal heparinization in coronary angioplasty: how much heparin is really warranted? Am J Cardiol 2000;85:953-6.
9. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wiéken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol 1997;29:1269-75.
10. Kuiper KK, Nordrehaug JE. Early mobilization after protamine reversal of heparin following implantation of phosphorylcholine-coated stents in totally occluded coronary arteries. Am J Cardiol 2000;85:698-702.
11. Neidhart PP, Meier B, Polla BS, Schifferli JA, Morel DR. Fatal anaphylactoid response to protamine after percutaneous transluminal coronary angioplasty. Eur Heart J 1992;13:856-8.
12. Pan M, Suarez de Lezo J, Medina A, Romero M, Hernandez E, Segura J, et al. In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am J Cardiol 1997;80:1336-8.
13. Rabah M, Mason D, Muller DW, Hundley R, Kugelmass AD, Weiner B, et al. Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention. J Am Coll Cardiol 1999;34:461-7.
14. Sesana M, Vaghetti M, Albiero R, Corvaja N, Martini G, Sivieri G, et al. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invasive Cardiol 2000;12:395-9.
15. Silber S. Rapid hemostasis of arterial puncture sites with collagen in patients undergoing diagnostic and interventional cardiac catheterization. Clin Cardiol 1997;20:981-92.
16. Singh H, Cardella JF, Cole PE, Grassi CJ, MCCowan TC, Swan TL, et al. SCVIR Standards of Practice Committee. Society of Cardiovascular and Interventional Radiology. Quality Improvement Guidelines for Diagnostic Arteriography. J Vasc Interv Radiol 2002; 13:1-6.
17. Urdaneta F, Lobato EB, Kirby RR, Horrow JC. Noncardiogenic pulmonary edema associated with protamine administration during coronary artery bypass graft surgery. J Clin Anesth 1999;11:675-81.
18. Wakefield TW, Hantler CB, Wrobleski SK, Crider BA, Stanley JC. Effects of differing rates of protamine reversal of heparin anticoagulation. Surgery 1996;119:123-8.
19. Weiss ME, Adkinson NF Jr. Allergy to protamine. Clin Rev Allergy 1991;9:339-55.